Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Pharmacogenetics & Genomics

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/FPC.0b013e328326e0c7PMID 19177029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prospective Study of Warfarin Dosage Requirements Based on CYP2C9 and VKORC1 Genotypes

  2008cited by this paper
• CYP2C9 Genotype‐guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study

  2008cited by this paper
• An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients

  2008cited by this paper
• Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

  2008cited by this paper
• Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation

  2007cited by this paper
• Pharmacogenetics of warfarin: current status and future challenges

  2007cited by this paper
• Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients

  2007cited by this paper
• Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.

  2007cited by this paper
• APOE genotype makes a small contribution to warfarin dose requirements.

  2006cited by this paper
• Pharmacogenetics-based coumarin therapy.

  2006cited by this paper
• Increased Sensitivity to Warfarin After Heart Valve Replacement

  2006cited by this paper
• Association of warfarin dose with genes involved in its action and metabolism

  2006cited by this paper
• A warfarin‐dosing model in Asians that uses single‐nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9

  2006cited by this paper
• CYP2C9 polymorphism and warfarin sensitivity in Taiwan Chinese.

  2006cited by this paper
• Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements

  2006cited by this paper
• Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population

  2006cited by this paper
• Pharmacogenetics of Target Genes Across the Warfarin Pharmacological Pathway

  2006cited by this paper
• Warfarin: a case history in pharmacogenetics

  2005cited by this paper
• Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype

  2005cited by this paper
• Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

  2005cited by this paper
• Common VKORC1 and GGCX polymorphisms associated with warfarin dose

  2005cited by this paper
• Rapid, accurate genotyping of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 based on the use of denaturing HPLC

  2005cited by this paper
• Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

  2005cited by this paper
• The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen.

  2005cited by this paper
• Warfarin therapy is feasible in CYP2C9*3 homozygous patients.

  2004cited by this paper
• Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors

  2004cited by this paper
• Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

  2004cited by this paper
• Dietary vitamin K influences intra‐individual variability in anticoagulant response to warfarin

  2004cited by this paper
• Identification of the gene for vitamin K epoxide reductase

  2004cited by this paper
• Pharmacogenetics of oral anticoagulants.

  2003cited by this paper
• Population differences in S‐warfarin metabolism between CYP2C9 genotype‐matched Caucasian and Japanese patients

  2003cited by this paper
• Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

  2000cited by this paper
• Exaggerated initial response to warfarin following heart valve replacement.

  1999cited by this paper
• Warfarin Sensitivity after Mechanical Heart Valve Replacement

  1998cited by this paper
• Genetic association between sensitivity to warfarin and expression of CYP2C9*3.

  1997cited by this paper
• Interactions of Warfarin with Drugs and Food

  1994cited by this paper
• Height.weight.surface formula for the estimation of surface area in Chinese subjects.

  1937cited by this paper

• Review of Precision Medicine and Diagnosis of Neonatal Illness

  2025cites this paper
• Application of Loading Dose Warfarin in Postpartum Women with Pulmonary Embolism – a Prospective, Randomized, Double-Blind Trial

  2025cites this paper
• Machine Learning for Warfarin Therapy: A Systematic Review

  2025cites this paper
• Quantitative Comparison of the Predictive Accuracy of Warfarin Pharmacogenetic Dosing Algorithms Derived From Population Data of Different Ethnicities in the Chinese Population

  2025influential citation
• Warfarin Dose Maintenance Associated with CYP2C9*2 (rs1799853) and CYP2C9*3 (rs1057910) Gene Polymorphism in North Coastal Andhra Pradesh

  2024cites this paper
• Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy

  2024cites this paper
• Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients

  2024cites this paper
• Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping Review

  2024influential citation
• Cost-Effectiveness Analysis of Pharmacogenomics-Guided Versus Standard Dosing of Warfarin in Patients with Mechanical Prosthetic Heart Valve

  2024cites this paper
• Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations.

  2023cites this paper
• Developing Chinese race-specific warfarin dose prediction algorithms

  2023influential citation
• A Case of Unexplained Warfarin Resistance: A Case Report and Literature Review

  2023cites this paper
• Comparison of Maintenance Dose Predictions by Warfarin Dosing Algorithms Based on Chinese and Western Patients

  2022cites this paper
• Ethnic Diversity and Warfarin Pharmacogenomics

  2022cites this paper
• Precision medicine via the integration of phenotype-genotype information in neonatal genome project

  2022cites this paper
• Performance Evaluation of Warfarin Dose Prediction Algorithms and Effects of Clinical Factors on Warfarin Dose in Chinese Patients

  2021cites this paper
• Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials.

  2021cites this paper
• An Adapted Neural-Fuzzy Inference System Model Using Preprocessed Balance Data to Improve the Predictive Accuracy of Warfarin Maintenance Dosing in Patients After Heart Valve Replacement

  2021cites this paper
• Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype‐Based Dosing Algorithms

  2020cites this paper
• Comparison of the prediction performance of different warfarin dosing algorithms based on Chinese patients.

  2020cites this paper
• CYP2C9 and VKORC1 genotyping for the quality of long-standing warfarin treatment in Russian patients

  2020cites this paper
• Effect of SAMe-TT2R2 score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin

  2020cites this paper
• Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort

  2020cites this paper
• Effects of rare CYP2C9 alleles on stable warfarin doses in Chinese Han patients with atrial fibrillation.

  2020cites this paper
• Warfarin dosing algorithms: A systematic review

  2020cites this paper
• LRP1 polymorphisms associated with warfarin stable dose in Chinese patients: a stepwise conditional analysis.

  2020cites this paper
• The Algorithm with Multiple Genotypes on Optimal Warfarin Doses in Korean Patients

  2020cites this paper
• A network meta‐analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype‐based warfarin dosing strategies compared to traditional

  2020cites this paper
• Pharmacogenetic testing: 5 Questions

  2020cites this paper
• Pharmacogenomics of Antithrombotic Drugs

  2020cites this paper
• Warfarin dose requirement in patients having severe thrombosis or thrombophilia

  2019cites this paper
• FEP Medical Policy Manual FEP 2.04.48 Genotype-Guided Warfarin Dosing

  2019cites this paper
• PHARMACOGENETIQUE DE L’ACENOCOUMAROL : LES GENES IMPLIQUES DANS LA VARIABILITE DE LA REPONSE ET PROPOSITION D’UN ALGORITHME PREDICTIF DE LA DOSE POUR LA POPULATION MAROCAINE

  2019cites this paper
• Development and Validation of a Novel Warfarin Dosing Algorithm for Korean Patients With VKORC1 1173C

  2019cites this paper
• Cytochrome p450 and VKORC1 Genotyping for Treatment Selection and Dosing

  2019cites this paper
• Evaluation of the predictive performance of Bayesian dosing for warfarin in Chinese patients.

  2019cites this paper
• Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients

  2019cites this paper
• Pharmacogenetics in Cardiovascular Diseases

  2019cites this paper
• Precision dosing of warfarin: open questions and strategies

  2019cites this paper
• Efficacy and Safety of Genotype-Guided Warfarin Dosing in the Chinese Population: A Meta-analysis of Randomized Controlled Trials

  2019cites this paper
• Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants

  2019cites this paper
• Genotype-Guided Warfarin Dosing in Patients With Mechanical Valves: A Randomized Controlled Trial.

  2018cites this paper
• Genotype‐guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta‐analysis of randomized controlled trials

  2018cites this paper
• Genotype‐guided dosing versus conventional dosing of warfarin: A meta‐analysis of 15 randomized controlled trials

  2018cites this paper
• The Influence of CYP 2 C 9 and VKORC 1 Gene Polymorphisms on Optimal Warfarin Doses After Heart Valve Replacement

  2018influential citation
• Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants

  2018cites this paper
• Meta-Analysis of Genotype-Guided Versus Standard Dosing of Vitamin K Antagonists.

  2018cites this paper
• The dose individualisation of oral anticoagulants

  2018cites this paper
• The Effect of Demographic Factors and VKORC1 1639 G>A Genotypes on Estimated Warfarin Maintenance Dose in Iranian Patients Under Warfarin Therapy

  2018cites this paper
• Impact of CYP2C9 and VKORC1 Polymorphisms on Warfarin Sensitivity and Responsiveness in Jordanian Cardiovascular Patients during the Initiation Therapy

  2018cites this paper
• Genotype-guided warfarin dosing

  2018cites this paper
• Comparative performance of pharmacogenetics‐based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai population

  2018cites this paper
• Cytochrome p450 and VKORC1 Genotyping for Treatment Selection and Dosing

  2018influential citation
• Genotype-guided warfarin therapy: current status.

  2018cites this paper
• DNA sensors to assess the effect of VKORC1 and CYP2C9 gene polymorphisms on warfarin dose requirement in Chinese patients with atrial fibrillation

  2017cites this paper
• Development of a novel individualized warfarin dose algorithm based on a population pharmacokinetic model with improved prediction accuracy for Chinese patients after heart valve replacement

  2017cites this paper
• Warfarin-induced life-threatening bleeding associated with a CYP3A4 loss-of-function mutation in an acute limb ischemia patient: Case report and review of the literature.

  2017cites this paper
• The Value of Evidence in the Decision-Making Process for Reimbursement of Pharmacogenetic Dosing of Warfarin

  2017cites this paper
• Are Evidence Standards Different for Genomic‐ vs. Clinical‐Based Precision Medicine? A Quantitative Analysis of Individualized Warfarin Therapy

  2017cites this paper
• Pharmacogenetic Testing

  2017cites this paper
• Pharmacogenetics-based warfarin dose prediction algorithm for patients with heart valve replacement in Southeast China

  2017cites this paper
• Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial

  2017cites this paper
• Genetic Testing for Warfarin Dose Policy # 00245

  2017cites this paper
• Warfarin Dosing Algorithms Underpredict Dose Requirements in Patients Requiring ≥7 mg Daily: A Systematic Review and Meta‐analysis

  2017cites this paper
• Evaluation of 16 genotype-guided Warfarin Dosing Algorithms in 310 Korean Patients Receiving Warfarin Treatment: Poor Prediction Performance in VKORC1 1173C Carriers.

  2016cites this paper
• Verification of five pharmacogenomics-based warfarin administration models

  2016cites this paper
• Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population

  2016cites this paper
• Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis

  2016cites this paper
• Warfarin Pharmacogenetics Reevaluated:  Subgroup Analysis Reveals a Likely Underestimation of the Maximum Pharmacogenetic Benefit by Clinical Trials.

  2016cites this paper
• Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients

  2016cites this paper
• Impact of the CYP4F2 gene polymorphisms on the warfarin maintenance dose: A systematic review and meta-analysis.

  2016cites this paper
• Pharmacogenetics of coumarin anticoagulant therapy

  2015cites this paper
• Pharmacogenetic-guided algorithms to estimate personalized dose or individual responses to anti-thrombotic drugs

  2015cites this paper
• Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation

  2015influential citation
• Meta-analysis of randomized controlled trials reveals an improved clinical outcome of using genotype plus clinical algorithm for warfarin dosing

  2015cites this paper
• Oral anticoagulation: a critique of recent advances and controversies.

  2015cites this paper
• Validation of warfarin pharmacogenetic algorithms in 586 Han Chinese patients.

  2015cites this paper
• Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: meta-analysis of randomized controlled trials.

  2015cites this paper
• Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database

  2015cites this paper
• Genotype-Guided Dosing of Coumarin Anticoagulants

  2015cites this paper
• Genotype-guided drug prescribing: a systematic review and meta-analysis of randomized control trials

  2015cites this paper
• Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials

  2015cites this paper
• Acenocoumarol Pharmacogenetic Dosing Algorithms and Their Application in Two Bulgarian Patients with Low Anticoagulant Requirements

  2015cites this paper
• Methods for Predicting Warfarin Dose Requirements

  2015cites this paper
• Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials

  2015influential citation
• Meta-analysis of Randomized Controlled Trials of Genotype-Guided vs Standard Dosing of Warfarin.

  2015cites this paper
• Pharmacogenetics-based Warfarin Dosing Algorithm Decreases Time to Stable Anticoagulation and the Risk of Major Hemorrhage: An Updated Meta-analysis of Randomized Controlled Trials

  2015cites this paper
• Genotype-guided coumarin dosing: where are we now and where do we need to go next?

  2015cites this paper
• Effect of CYP2C9–VKORC1 interaction on warfarin stable dosage and its predictive algorithm

  2015cites this paper
• Comparison of the Performance of the Warfarin Pharmacogenetics Algorithms in Patients with Surgery of Heart Valve Replacement and Heart Valvuloplasty.

  2015influential citation
• Outcomes of pharmacogenetics-guided dosing of warfarin: a systematic review and meta-analysis.

  2014influential citation
• Study Of Genetic And Pharmacokinetic Issues Related To Efficacy And Toxicity Of Warfarin In Pakistani Subjects

  2014cites this paper
• VKORC1 and CYP2C9 genotype distribution in Asian countries.

  2014cites this paper
• Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients

  2014cites this paper
• Verification of Pharmacogenetics-Based Warfarin Dosing Algorithms in Han-Chinese Patients Undertaking Mechanic Heart Valve Replacement

  2014cites this paper
• Simultaneous Use of Amiodarone Influences Warfarin Maintenance Dose but Is Not Associated with Adverse Events

  2014cites this paper
• The COAG and EU-PACT trials: what is the clinical benefit of pharmacogenetic-guided coumarin dosing during therapy initiation?

  2014cites this paper
• Personalized genomes and cardiovascular disease.

  2014cites this paper
• Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon.

  2014cites this paper
• Pharmacogenetics role in the safety of acenocoumarol therapy

  2014cites this paper